Focused cancer pathway analysis revealed unique therapeutic targets in retinoblastoma

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Retinoblastoma (RB) is a common pediatric eye cancer initiated by RB1 gene inactivation.
• Disease progression in RB is significantly influenced by transcriptional alterations.
• Identifying gene expression changes is crucial for discovering therapeutic targets in RB management.

Purpose of the Study:

• To investigate gene expression profiles in retinoblastoma tumors.
• To identify dysregulated genes and pathways involved in RB pathogenesis.
• To uncover potential molecular targets for improved retinoblastoma treatment.

Main Methods:

• Utilized RT² Profiler™ PCR array for focused analysis of 84 cancer-specific genes in 13 RB tumors.
• Validated key transcript alterations in an additional 15 RB tumors using RT-qPCR.
• Constructed an interaction network from gene expression data to identify dysregulated pathways.
• Confirmed protein-level dysregulation of identified targets via Western blot.

Main Results:

• Out of 84 genes analyzed, 68 were found to be dysregulated in RB tumors.
• Pathway analysis revealed frequent perturbations in cell cycle, angiogenesis, and apoptotic pathways.
• Consistent upregulation of MCM2, MKI67, PGF, WEE1, CDC20, and downregulation of COX5A were observed across all tumors.
• Molecular alterations were more pronounced in invasive RB, correlating with disease pathogenesis.

Conclusions:

• The study identified significant molecular alterations and potential therapeutic targets for retinoblastoma.
• Specific genes like MCM2, MKI67, PGF, WEE1, CDC20, and COX5A are key players in RB progression.
• PCR array technology offers a rapid and cost-effective method for gene expression analysis in RB research.